Full Text
Differences Between The Efficacy of Biosimilars and Originators - Analysis and Implications for The Cost-Effectiveness-Analysis From A Payers Perspective

Abstract

Authors

M Bierbaum A Haffer ME Bierbaum

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×